HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret R MacLean Selected Research

5-HT1B Serotonin Receptor

1/2017Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension.
2/2010In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.
8/2005Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret R MacLean Research Topics

Disease

30Pulmonary Arterial Hypertension
01/2023 - 03/2006
29Pulmonary Hypertension
01/2023 - 02/2002
16Hypoxia (Hypoxemia)
04/2020 - 12/2002
11Vascular Remodeling
01/2022 - 05/2004
8Right Ventricular Hypertrophy
06/2021 - 02/2002
3Vascular Diseases (Vascular Disease)
01/2023 - 08/2005
3Inflammation (Inflammations)
01/2022 - 03/2012
3Familial Primary Pulmonary Hypertension
01/2021 - 01/2007
3Left Ventricular Dysfunction
05/2006 - 02/2002
2Neoplasms (Cancer)
01/2021 - 03/2012
2Obesity
01/2021 - 07/2020
2Fibrosis (Cirrhosis)
10/2020 - 01/2013
2Vascular System Injuries
01/2017 - 03/2012
1Body Weight (Weight, Body)
07/2022
1Hypertension (High Blood Pressure)
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Hypertrophy
10/2020
1Carcinoma (Carcinomatosis)
06/2020
1Heart Diseases (Heart Disease)
03/2012

Drug/Important Bio-Agent (IBA)

16Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 05/2004
13Estrogens (Estrogen)FDA Link
07/2022 - 08/2012
10MicroRNAs (MicroRNA)IBA
01/2021 - 04/2010
6Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2002
6Semaxinib (SU5416)IBA
04/2020 - 01/2013
6Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2017 - 08/2005
4Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
01/2021 - 03/2006
4Aromatase (CYP19)IBA
01/2021 - 08/2014
3Serotonin ReceptorsIBA
06/2020 - 05/2005
3Estradiol (Delestrogen)FDA LinkGeneric
01/2020 - 05/2011
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2019 - 08/2012
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2016
35-HT1B Serotonin ReceptorIBA
01/2017 - 08/2005
3Messenger RNA (mRNA)IBA
05/2004 - 12/2002
2AminorexIBA
01/2022 - 06/2008
2salicylhydroxamic acid (SHAM)IBA
10/2020 - 02/2002
2LeptinIBA
07/2020 - 01/2019
2Mitogen-Activated Protein KinasesIBA
04/2020 - 04/2003
2Anastrozole (Arimidex)FDA LinkGeneric
01/2019 - 01/2016
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
06/2015 - 03/2006
2Dexfenfluramine (Redux)IBA
07/2013 - 06/2008
2EnzymesIBA
07/2013 - 08/2012
2Tryptophan HydroxylaseIBA
01/2013 - 01/2007
2Endothelin-1 (Endothelin 1)IBA
07/2006 - 02/2002
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
07/2006 - 12/2002
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
04/2003 - 12/2002
1Notch3 ReceptorIBA
01/2023
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2022
1FenfluramineIBA
01/2022
1Chlorphentermine (Chlorphentermine Hydrochloride)FDA Link
01/2022
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2021
1Methamphetamine (Desoxyn)FDA LinkGeneric
06/2021
1Cytochrome P450 Family 19IBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021
1MelatoninIBA
11/2020
1Atrial Natriuretic Factor (ANF)IBA
10/2020
1Collagen Type I (Type I Collagen)IBA
10/2020
1Natriuretic PeptidesIBA
10/2020
1SteroidsIBA
07/2020
1AdiponectinIBA
07/2020
1CytokinesIBA
04/2020
1MAP Kinase Kinase Kinase 5IBA
04/2020
1Fulvestrant (Faslodex)FDA Link
11/2019
1Therapeutic UsesIBA
01/2019
12-MethoxyestradiolIBA
01/2019
12,2',4,6'-tetramethoxystilbeneIBA
01/2019
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2018
1AntioxidantsIBA
01/2017
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2017
1NADPH Oxidase 1IBA
01/2017
1Oxidoreductases (Dehydrogenase)IBA
01/2016
1AMP-Activated Protein KinasesIBA
01/2016
1Metformin (Glucophage)FDA LinkGeneric
01/2016
1NADP (NADPH)IBA
01/2016
1Estrogen ReceptorsIBA
10/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2015
1hexachlorocyclohexane x-factorIBA
10/2015
1hydralazine 4-anisaldehyde hydrazoneIBA
03/2015
1Caspase 3 (Caspase-3)IBA
07/2014
1Imatinib Mesylate (Gleevec)FDA Link
01/2013
1CollagenIBA
01/2013
1AntagomirsIBA
07/2012
1MonocrotalineIBA
04/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2010
1LY 393558IBA
02/2010
1CitalopramFDA LinkGeneric
02/2010
1p38 Mitogen-Activated Protein KinasesIBA
06/2008
1Phospholipases (Phospholipase)IBA
07/2006
1Prostaglandins EIBA
07/2006
1Cyclooxygenase InhibitorsIBA
07/2006
1MitogensIBA
07/2006
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2006
1U 0126 (UO 126)IBA
07/2006

Therapy/Procedure

2Therapeutics
12/2020 - 06/2020
2Ovariectomy (Oophorectomy)
03/2015 - 05/2011
2Ligation
05/2006 - 02/2002
1Subcutaneous Injections
04/2020
1Stents
03/2012